MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD

Press/Media: Public EngagementPopular


MindMed (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), a biotech company developing psychedelic-inspired therapies, announced its financial results ... As part of the study conducted by Dr. Kim Kuypers of Maastricht University, researchers will use digital measurement devices and software ...

Period16 Nov 2021

Media coverage


Media coverage


  • BDNF plasma levels
  • LSD on neuroplasticity
  • MindMed's shares
  • board directors
  • cash
  • cognitive performance
  • development
  • effects of daytime
  • financial results
  • individuals to access levels